The Treatment of Cardiovascular Disease Continuum: Focus on Pharmacologic Management and RAS Blockade
Journal:
Current Clinical Pharmacology
Volume:
5
Page:
89-95
Author(s):
Steven G. Chrysant, George S. Chrysant, Catherine Chrysant and Mohammad Shiraz
Bone Disease in Diabetes
Journal:
Current Diabetes Reviews
Volume:
6
Page:
144-155
Author(s):
M Luisa Isidro and Belen Ruano
Aliskiren, a Direct Renin Inhibitor, in Clinical Practice: A New Approach in the Treatment of Hypertension
Journal:
Current Vascular Pharmacology
Volume:
8
Page:
344-362
Author(s):
Elisavet Moutzouri, Matilda Florentin, Moses S. Elisaf, Dimitri P. Mikhailidis and Evangelos N. Liberopoulos
Perspectives on Medicinal Properties of Benzoquinone Compounds
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
10
Page:
436-454
Author(s):
P.R. Dandawate, A.C. Vyas, S.B. Padhye, M.W. Singh and J.B. Baruah
Anti-Vasopermeability Effects of PEDF in Retinal-Renal Disorders
Journal:
Current Molecular Medicine
Volume:
10
Page:
279-283
Author(s):
S. Ueda, S.-I. Yamagishi and S. Okuda
TGF-β Pathway as a Therapeutic Target in Bone Metastases
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
1301-1312
Author(s):
Patricia Juarez and Theresa A. Guise
Novel Anti-Inflammatory and Neuroprotective Agents for Parkinsons Disease
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
9
Page:
232-240
Author(s):
Li Lu, Fengqiao Li and Xiaomin Wang
HMGB1-Directed Drug Discovery Targeting Cutaneous Inflammatory Dysregulation
Journal:
Current Drug Metabolism
Volume:
11
Page:
250-265
Author(s):
Sarah D. Lamore, Christopher M. Cabello and Georg T. Wondrak
Ascorbic Acid and Gene Expression: Another Example of Regulation of Gene Expression by Small Molecules?
Journal:
Current Genomics
Volume:
11
Page:
52-57
Author(s):
Sophie Belin, Ferdinand Kaya, Stephane Burtey and Michel Fontes
Cell-Permeable Peptide Inhibitor of c-Jun NH2-Terminal Kinase for the Treatment of Diabetes
Journal:
Current Bioactive Compounds
Volume:
6
Page:
23-30
Author(s):
Hirofumi Noguchi